Tag: drug development
Parexel appoints Charlotte Moser as its Chief Medical Officer
Veteran Oncologist and Clinical Development expert to lead global medical strategy supporting patient-focused drug development and delivery
BioVoice eMagazine March 2025 | Issue 3 | Volume 6
The Cover Story tracks the surge in the big-ticket investments by MNCs to spearhead the next wave of innovation. Read interview of Shailendra Vyas CEO and Director, Bioheaven360 Genotec. Expert Insights by Shereef Rehuman, MD, ICEXPO Consults and Daara Patel, Secretary General, IDMA; and Ninad Karandikar, Co-founder, Stance Health
Zydus Lifesciences completes Phase II(a) clinical trial of Usnoflast in ALS...
Usnoflast, a novel oral NLRP3 inflammasome inhibitor, shows promising results in reducing neurodegeneration and improving key health markers
Parexel expands real-world research capabilities with new leadership
Mike D’Ambrosio appointed as Senior Vice President, Global Head of Real World Research, to enhance evidence-based approaches
Biostate AI unveils revolutionary RNA Sequencing and OmicsWeb Copilot
Introducing advanced tools for affordable and scalable RNAseq data analysis and data visualization in biotech and pharma sectors
PULSUS Group to invest ₹300 crore in AI-based pharma healthcare IT...
A new hub in Telangana to generate 50,000 jobs, enhance drug development precision, position the state as a leader in healthcare innovation
Orchid Pharma and Cipla to launch antibiotic Cefepime-Enmetazobactam in India
The partnership aims to address antimicrobial resistance through the rapid deployment of novel treatments for serious infections
GSK acquires oligonucleotide drug startup Elsie
This follows a successful research collaboration with Elsie, announced in July 2023, in which GSK was able to explore and validate the technology
Aragen & Getinge’s SUPR bioreactors scale antibody production from 2L to...
Successful GMP validation of 50L and 250L SUPRs promises to transform biopharmaceutical manufacturing, offering seamless scale-up from research to production
Anti-obesity drugs to dominate biopharma trends in 2024, reports GlobalData
Survey reveals obesity medications as key driver for industry growth in biopharmaceutical sector





























































